Emma Guttman, MD, PhD
img_Emma Guttman
PROFESSOR | Medicine, Clinical Immunology
Are you a patient?
Multi-Disciplinary Training Area
Immunology [IMM]
Inflammatory Skin Diseases
Dr. Guttman’s groundbreaking research focuses on atopic dermatitis/eczema and contact dermatitis. Her research has important implications in advancing the current molecular knowledge on atopic dermatitis/eczema and developing new therapeutics. Dr. Guttman currently develops biomarkers of atopic dermatitis that could be used for future studies with targeted therapeutics. She also concentrates on unraveling the primary pathogenesis of this common disease. She is the recipient of the prestigious Young Investigator Award (2011) from the of Dermatology, the 2011 recipient of the Dermatology Foundation’s Physician-Scientist Career Development Award, and the recipient of the Fisher award of the American Contact Dermatitis Society 2011.

MD, Tel-Aviv University Sackler School Of Medicine

Residency, Dermatology, Rambam Medical Center/Technion

Internship, Internal Medicine, Memorial Sloan-Kettering Cancer Center

Residency, Dermatology, Weill Cornell Medical College-New York Hospital


Keynote Lecture: Atopic Dermatitis: The Road to a Personalized Medicine Approach, the 51st ESDR Annual Meeting

European Society for Dermatological Research (ESDR)


Donald Y. M. Leung, MD, PhD, the JACI Editors’ Lectureship and Faculty Development Award, the 2021 AAAAI Virtual Annual Meeting

American Academy of Allergy, Asthma & Immunology (AAAAI)


Article of the Year Award: “Transcriptomic Profiling of Tape-Strips from Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab”

American Contact Dermatitis Society (ACDS) Editorial/Publications Committee


Bettina C. Hilman, MD Lectureship and Award

American Academy of Allergy and Immunology (AAAAI)


Elected as one of 4 international organizers (two from US and two from EU) of the 2nd Keystone Symposia on Skin Health and Disease: Immune, Microbiome and Epithelia crosstalk

Keystone Symposia


Hugh A. Sampson Lectureship and Award

American Academy of Allergy and Immunology (AAAAI)


President, International Eczema Council

International Eczema Council


Elected to the board of the American Skin Association (ASA)

American Skin Association (ASA)


Young Investigator Award (2011)

American Academy of Dermatology

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Guttman during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • Boston Pharmaceuticals
  • Schrodinger Inc
  • GlaxoSmithKline
  • Pfizer Inc.
  • Incyte Corporation
  • Q32 Bio
  • Eli Lilly and Company
  • RAPT Therapeutics
  • sanofi-aventis
  • Cara Therapeutics
  • SATO Pharmaceuticals
  • Bluefin
  • Evommune Inc
  • Almirall, S.A.
  • Galderma S.A.
  • Amgen Inc.
  • Bristol-Myers Squibb
  • Escient Pharmaceuticals
  • Allergan, Inc. / MAP Pharmaceuticals, Inc. collaboration
  • Kyowa Kirin Co., Ltd.
  • ribon therapeutics
  • AbbVie Inc.
  • Aslan Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Janssen Pharmaceuticals, Inc.
  • Genzyme Corporation
  • LEO Pharma A/S
  • connect Biopharma
  • AnaptysBio
  • Arcutis Biotherapeutics

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.